"T1: heterogeneously isointense to muscle with multiple hypointense and hyperintense foci"
"T2: heterogeneously hyperintense with flow voids"
"STIR/PDFS: heterogeneously hyperintense with flow voids"
"T1C+ (Gd): heterogeneous enhancement"
"The main treatment of pleomorphic hyalinizing angiectatic tumours consists of wide surgical excision 1,2. Up to 50% of the resected lesions show local recurrence which can be usually cured by re-excision. In extremely rare situations, pleomorphic hyalinizing angiectatic tumours of soft parts have been reported to progress to myxoid sarcoma but the exact relationship is unclear 1."
"Pleomorphic hyalinizing angiectatic tumours (PHAT) of soft parts is diagnosed based on typical histological and molecular pathological features."
"T1: heterogeneously isointense to muscle with multiple hypointense and hyperintense foci"
"T2: heterogeneously hyperintense with flow voids"
"STIR/PDFS: heterogeneously hyperintense with flow voids"
"T1C+ (Gd): heterogeneous enhancement"
"TGFBR3 and/or OGA rearrangement"
"Similar to haemosiderotic fibrolipomatous tumours, pleomorphic hyalinizing angiectatic tumours of soft parts are associated with rearrangements of the TGFBR3 and or OGA genes 1,2."
"US"
"US"
"Kaposi sarcoma"
Expected headings
"US"
"Signal characteristics"
"Pleomorphic hyalinizing angiectatic tumours are most commonly found in the subcutaneous tissues of the lower extremities e.g. the ankle and foot. Rarely they have been described in the deep soft tissues of the perineum, buttock, arm or retroperitoneum 1-3."
"form, location and size"